Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant GPC3 (Codrituzumab Biosimilar) antibody

Reactivity: Human ELISA, FACS, SPR, Func, BLI Host: Human Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7581429
  • Target See all GPC3 (Codrituzumab Biosimilar) products
    GPC3 (Codrituzumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    • 1
    Human
    Expression System
    CHO Cells
    Clonality
    • 2
    Monoclonal
    Conjugate
    • 2
    This GPC3 (Codrituzumab Biosimilar) antibody is un-conjugated
    Application
    ELISA, Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Functional Studies (Func), Bio-Layer Interferometry (BLI)
    Purpose
    Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab)
    Sequence
    QVQLVQSGAE VKKPGASVKV SCKASGYTFT DYEMHWVRQA PGQGLEWMGA LDPKTGDTAY SQKFKGRVTL TADKSTSTAY MELSSLTSED TAVYYCTRFY SYTYWGQGTL VTVSSASTKG PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL SSVVTVPSSS LGTQTYICNV NHKPSNTKVD KKVEPKSCDK THTCPPCPAP ELLGGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSRDELTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK,DVVMTQSPLS LPVTPGEPAS ISCRSSQSLV HSNRNTYLHW YLQKPGQSPQ LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCSQNTHVP PTFGQGTKLE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
    Characteristics
    Anti-GPC3 / Glypican-3 Reference Antibody (codrituzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
    Purity
    >95 %
    Isotype
    IgG1
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Therapeutic Agents by Target and Mechanism: GPC3 inhibitors, ADCC, Antibody-dependent phagocytosis

    Conditions: Liver Cancer  

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    1 mg/mL
    Buffer
    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
    Storage
    4 °C,-80 °C
    Storage Comment
    +4°C,-80°C
  • Target
    GPC3 (Codrituzumab Biosimilar)
    Abstract
    GPC3 (Codrituzumab Biosimilar) Products
    Target Type
    Biosimilar
    Background
    Synonyms: GPC3
    Molecular Weight
    145.5 kDa
    UniProt
    P51654
You are here:
Support